VEGFA targeting in capillary hemangiomas.
Department of Radiology, Institut Bergonié, Bordeaux, France.
Gaultier
G
Marnat
Department of Pathology, Institut Bergonié, Bordeaux, France.
Jean-Michel
JM
Coindre
Department of Medical Oncology, Institut Bergonié, Bordeaux, France. a.italiano@bordeaux.unicancer.fr.|Early Phase Trials and Sarcoma Units, Institut Bergonié, 229 cours de l'Argonne, 33000, Bordeaux, France. a.italiano@bordeaux.unicancer.fr.
Antoine
A
Italiano
D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000818:Animals; D003907:Dexamethasone / Q000494:pharmacology*; D005938:Glucocorticoids / Q000494:pharmacology*; D006391:Hemangioma / Q000378:metabolism*; D006801:Humans; D039902:Multipotent Stem Cells / Q000187:drug effects*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
D020533:Angiogenesis Inhibitors; D005938:Glucocorticoids; D042461:Vascular Endothelial Growth Factor A; D003907:Dexamethasone